Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study ; volume:33 ; number:5 ; day:15 ; month:1 ; year:2022 ; pages:1155-1164 ; date:5.2022
Osteoporosis international ; 33, Heft 5 (15.1.2022), 1155-1164, 5.2022
- Creator
-
Lai, E. C.-C
Lin, T.-C
Lange, J. L.
Chen, L.
Wong, I. C. K.
Sing, C.-W
Cheung, C.-L
Shao, S.-C
Yang, Y.-H. Kao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-021-06291-w
- URN
-
urn:nbn:de:101:1-2022062822171729129342
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lai, E. C.-C
- Lin, T.-C
- Lange, J. L.
- Chen, L.
- Wong, I. C. K.
- Sing, C.-W
- Cheung, C.-L
- Shao, S.-C
- Yang, Y.-H. Kao
- SpringerLink (Online service)
Other Objects (12)
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
Postmenopausal osteoporosis
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Real-world treatment and fracture incidence in postmenopausal women with severe osteoporosis at high risk of fracture: a retrospective claims data analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
Postmenopausal osteoporosis
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Real-world treatment and fracture incidence in postmenopausal women with severe osteoporosis at high risk of fracture: a retrospective claims data analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
Postmenopausal osteoporosis
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Real-world treatment and fracture incidence in postmenopausal women with severe osteoporosis at high risk of fracture: a retrospective claims data analysis
Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Geography of Fracture Incidence in Postmenopausal Women with Osteoporosis Treated with Abaloparatide